742 related articles for article (PubMed ID: 20130375)
21. Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.
Towne TG; Lewis JS; Herrera M; Wickes B; Jorgensen JH
J Clin Microbiol; 2010 Jan; 48(1):298-9. PubMed ID: 19923476
[TBL] [Abstract][Full Text] [Related]
22. Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.
Poulou A; Grivakou E; Vrioni G; Koumaki V; Pittaras T; Pournaras S; Tsakris A
J Clin Microbiol; 2014 May; 52(5):1483-9. PubMed ID: 24574283
[TBL] [Abstract][Full Text] [Related]
23. Comparison of different phenotypic assays for the detection of extended-spectrum β-lactamase production by inducible AmpC-producing Gram-negative bacilli.
Willems E; Cartuyvels R; Magerman K; Raymaekers M; Verhaegen J
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):549-55. PubMed ID: 23135757
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
Morrissey I; Bouchillon SK; Hackel M; Biedenbach DJ; Hawser S; Hoban D; Badal RE
J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
[TBL] [Abstract][Full Text] [Related]
26. Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results.
Tenover FC; Emery SL; Spiegel CA; Bradford PA; Eells S; Endimiani A; Bonomo RA; McGowan JE
J Clin Microbiol; 2009 Feb; 47(2):294-9. PubMed ID: 19036936
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2005 Jul; 39(3):265-72. PubMed ID: 16358485
[TBL] [Abstract][Full Text] [Related]
28. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.
Wang P; Hu F; Xiong Z; Ye X; Zhu D; Wang YF; Wang M
J Clin Microbiol; 2011 Sep; 49(9):3127-31. PubMed ID: 21752977
[TBL] [Abstract][Full Text] [Related]
30. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
[TBL] [Abstract][Full Text] [Related]
31. Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL.
M'Zali FH; Chanawong A; Kerr KG; Birkenhead D; Hawkey PM
J Antimicrob Chemother; 2000 Jun; 45(6):881-5. PubMed ID: 10837444
[TBL] [Abstract][Full Text] [Related]
32. An Increase in the clinical isolation of acquired AmpC β-lactamase-producing Klebsiella pneumoniae in Korea from 2007 to 2010.
Park MJ; Kim TK; Song W; Kim JS; Kim HS; Lee J
Ann Lab Med; 2013 Sep; 33(5):353-5. PubMed ID: 24003426
[TBL] [Abstract][Full Text] [Related]
33. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.
Queenan AM; Foleno B; Gownley C; Wira E; Bush K
J Clin Microbiol; 2004 Jan; 42(1):269-75. PubMed ID: 14715764
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Phenotypic Tests to Detect Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella oxytoca Complex Strains.
Campos-Madueno EI; Moser AI; Keller PM; Perreten V; Poirel L; Nordmann P; Endimiani A
J Clin Microbiol; 2023 Apr; 61(4):e0170622. PubMed ID: 36912648
[TBL] [Abstract][Full Text] [Related]
35. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
36. Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.
Zemelman C; Bello H; Domínguez M; González G; Mella S; Zemelman R
Diagn Microbiol Infect Dis; 2001; 40(1-2):41-3. PubMed ID: 11448562
[TBL] [Abstract][Full Text] [Related]
37. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Sabia C; Gargiulo R; Sarti M
New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the boronic acid disk potentiation test and cefepime-clavulanic acid method for the detection of ESBL among AmpC-producing Enterobacteriaceae.
Shoorashetty RM; Nagarathnamma T; Prathibha J
Indian J Med Microbiol; 2011; 29(3):297-301. PubMed ID: 21860114
[TBL] [Abstract][Full Text] [Related]
40. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
Hombach M; Mouttet B; Bloemberg GV
J Antimicrob Chemother; 2013 Sep; 68(9):2092-8. PubMed ID: 23633681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
